Elelyso (Taliglucerase Alfa) for Treating Gaucher Disease

Elelyso (taliglucerase alfa) is an intravenous drug indicated for the treatment of type one Gaucher disease. The drug was jointly developed by Protalix BioTherapeutics and Pfizer.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news